1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Central America Pharmaceuticals and Healthcare Report Q2 2015

Central America Pharmaceuticals and Healthcare Report Q2 2015

  • February 2015
  • -
  • Business Monitor International
  • -
  • 60 pages

Includes 3 FREE quarterly updates

BMI View:

A growing ageing population, favourable tax incentives and high demand for medicines confirm Central America's ability to continue offering revenue-generating opportunities to foreign drugmakers. However, the region's growing preference for traditional medicines could interfere with productive sales in coming years.

Headline Expenditure Projections

- Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +5.6%. Our forecast has been revised upwards since Q115 due to historical data.
- Healthcare: USD16.8bn in 2014 to USD17.8bn in 2015; +5.7 %. Our forecast has been revised upwards since Q115 due to revised historical data.

Table Of Contents

Central America Pharmaceuticals and Healthcare Report Q2 2015
BMI Industry View 7
SWOT 9
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Guatemala 12
Table: Guatemala Pharmaceutical Sales Forecasts 12
Costa Rica 13
Table: Costa Rica Pharmaceutical Sales Forecasts 14
El Salvador 14
Table: El Salvador Pharmaceutical Sales Forecasts 15
Honduras 15
Table: Honduras Pharmaceutical Sales Forecasts 15
Panama 15
Table: Panama Pharmaceutical Sales Forecasts 16
Nicaragua 16
Table: Nicaragua Pharmaceutical Sales Forecasts 16
Healthcare Market Forecast 16
Table: Central America Healthcare Expenditure Trends, Historical Data And Forecasts 17
Guatemala 17
Table: Guatemala Healthcare Expenditure Forecasts 18
Costa Rica 18
Table: Costa Rica Healthcare Expenditure Forecasts 18
El Salvador 18
Table: El Salvador Healthcare Expenditure Forecasts 20
Panama 20
Table: Panama Healthcare Expenditure Forecasts 20
Honduras 20
Table: Honduras Healthcare Expenditure Forecasts 21
Nicaragua 21
Table: Nicaragua Healthcare Expenditure Forecasts 21
Pharmaceutical Trade Forecast 22
Guatemala 24
Table: Guatemala Pharmaceutical Trade Data And Forecasts (USDmn) 24
Costa Rica 24
Table: Costa Rica Pharmaceutical Trade Data And Forecasts (USDmn) 24
El Salvador 25
Table: El Salvador Pharmaceutical Trade Data And Forecasts (USDmn) 25
Panama 25
Table: Panama Pharmaceutical Trade Data And Forecasts (USDmn) 26
Honduras 26
Table: Honduras Pharmaceutical Trade Data And Forecasts (USDmn) 26
Nicaragua 26
Table: Nicaragua Pharmaceutical Trade Data And Forecasts (USDmn) 27
Industry Risk Reward Ratings 28
Americas Risk/Reward Index 28
Central America Risk/Reward Index 33
Industry Trends And Developments 34
Epidemiology 34
Regional Developments 35
Guatemala 36
Costa Rica 37
El Salvador 39
Panama 40
Honduras 40
Nicaragua 41
Clinical Trials 42
Regulatory Development 45
Intellectual Property Regime 45
Costa Rica 46
El Salvador 47
Honduras 47
Nicaragua 48
Guatemala 48
Competitive Landscape 49
Company Profile 50
Ancalmo Internacional 50
Donovan Werke 52
Glossary 54
Methodology 56
Pharmaceutical Expenditure Forecast Model 56
Healthcare Expenditure Forecast Model 56
Notes On Methodology 57
Risk/Reward Index Methodology 58
Index Overview 59
Table: Pharmaceutical Risk/Reward Index Indicators 59
Indicator Weightings 60

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.